New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
OrganiGram Holdings Inc.
OGI.TO
Shape
US Flag

TSX

Unprofitable

EPS improving

Unprofitable

EPS improving

264M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Dec 2024

264M

Drug Manufacturers - Specialty & Generic

Next Earning date - 17 Dec 2024

2.44CAD
Shape-0.01 ( -0.20%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 22, 2024
1W 2.52 % 1M 0.00 % 3M 0.41 % 1Y 75.54 %

Key Metrics

Shape
  • Market Cap

    264.38M


  • Shares Outstanding

    108.57M


  • Share in Float

    75.85M


  • Dividende

    0


  • Earning Date

    17 Dec 2024


  • Price Target

    2.435


  • Average Volume

    225546


  • Beta

    1.128


  • Range

    1.35-3.95


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.organigram.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.64x

P/S Ratio

0.85x

P/B Ratio

0.0

Debt/Equity

-45.3%

Net Margin

$-2.5

EPS

How OGI.TO compares to sector?

P/E Ratio

Relative Strength

Shape

OGI.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$184M

Shape347%

2025-Revenue

$0.11

Shape312%

2025-EPS

$58M

Shape-266%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.02
vs -0.09

Q4.22

arrow
arrow

+225%

0.02
vs -0.02

Q1.23

arrow
arrow

N/A

-0.02
vs -0.01

Q2.23

arrow
arrow

N/A

-0.68
vs -0.09

Q3.23

arrow
arrow

N/A

-0.41
vs -0.02

Q4.23

arrow
arrow

N/A

-0.19
vs 0.02

Q1.24

arrow
arrow

N/A

-0.26
vs -0.02

Q2.24

arrow
arrow

+104%

0.03
vs -0.68

Q3.24

arrow
arrow

N/A

-0.02
vs -0.41

Q4.24

arrow
arrow

N/A

-0.06
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+83%

45.5M  vs 24.9M

Q4.22

arrow
arrow

+43%

43.3M  vs 30.4M

Q1.23

arrow
arrow

+24%

39.5M  vs 31.8M

Q2.23

arrow
arrow

-14%

32.8M  vs 38.1M

Q3.23

arrow
arrow

+1%

46M  vs 45.5M

Q4.23

arrow
arrow

-16%

36.5M  vs 43.3M

Q1.24

arrow
arrow

-5%

37.6M  vs 39.5M

Q2.24

arrow
arrow

+25%

41.1M  vs 32.8M

Q3.24

arrow
arrow

+6%

48.8M  vs 46M

Q4.24

arrow
arrow

+28%

46.8M  vs 36.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.01

Q4.22

arrow
arrow

+1%

0.01
vs -0.01

Q1.23

arrow
arrow

-1%

-0.01
vs 0.01

Q2.23

arrow
arrow

-71%

-0.71
vs -0.01

Q3.23

arrow
arrow

-12%

-0.12
vs -0.71

Q4.23

arrow
arrow

-6%

-0.06
vs -0.12

Q1.24

arrow
arrow

-10%

-0.10
vs -0.06

Q2.24

arrow
arrow

+1%

0.01
vs -0.10

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News